Log in

Relevant bibliographies by topics / Nardostachys / Journal articles

To see the other types of publications on this topic, follow the link: Nardostachys.

Journal articles on the topic 'Nardostachys'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Nardostachys.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Bian, Li-hua, Zi-wei Yao, Cheng-bowen Zhao, Qiu-yu Li, Jin-li Shi, and Jian-you Guo. "Nardosinone Alleviates Parkinson’s Disease Symptoms in Mice by Regulating Dopamine D2 Receptor." Evidence-Based Complementary and Alternative Medicine 2021 (August 13, 2021): 1–14. http://dx.doi.org/10.1155/2021/6686965.

Full text

Abstract:

Nardostachyos Radix et Rhizoma (nardostachys) is the root and rhizome of Nardostachys jatamansi DC. Recent studies have shown that nardostachys may exert an anti-PD effect. In this study, the UHPLC-LTQ-Orbitrap-MS method was used to analyze the brain components of nardostachys in rats. Based on the results of UHPLC-LTQ-Orbitrap-MS analysis, nardosinone was identified to be the most effective anti-PD compound in nardostachys. To further verify this inference, a mouse PD model was established and the effect of nardosinone on PD mice was determined using classic behavioral tests. The results showed that nardosinone was indeed effective for relieving PD symptoms in mice. Moreover, network pharmacology analysis was used to elucidate the mechanism underlying the anti-PD effect of nardosinone. Dopamine receptor D2 (DRD2) was identified as the key target of nardosinone-PD interaction network, which was further verified by molecular docking and Western blotting. The results demonstrated that nardosinone and DRD2 could interact with each other. Furthermore, the expression level of DRD2 was decreased in the brain tissue of PD mice, and nardosinone could restore its expression to a certain extent. In conclusion, our findings suggest that nardosinone may reduce the motor and cognitive symptoms in the animal PD model by regulating DRD2 expression.

APA, Harvard, Vancouver, ISO, and other styles

2

Li, Junjun, Jie Wu, Kezhong Peng, Gang Fan, Haiqing Yu, Wenguo Wang, and Yang He. "Simulating the effects of climate change across the geographical distribution of two medicinal plants in the genus Nardostachys." PeerJ 7 (April 16, 2019): e6730. http://dx.doi.org/10.7717/peerj.6730.

Full text

Abstract:

Background The medicinal plants of Radix et Rhizoma Nardostachyos include Nardostachys jatamansi and N. chinensis. Traditionally, the two plants have been used to treat many diseases. Because of their special aroma, they are also commonly used in the food and cosmetics industry. Recently, N. jatamansi and N. chinensis have been overexploited due to their economic importance, resulting in a sharp decline in their wild resources. Predicting potential distributions of the genus Nardostachys under different climate scenarios and understanding its preferred habitat are of great significance for their conservation, artificial cultivation, and assessment of their value. Methods The Maxent model was used to predict the potential geographical distributions of the genus Nardostachys under current and future climatic conditions based on two representative concentration pathways (RCP2.6 and RCP8.5) for the 2050s and 2070s. These data were used to study the effects of climate variables. Results The results show that the potential distribution of the two species will increase, thus more suitable habitats will be present in China. The suitable habitat for N. chinensis presents a relatively stable growth compared to N. jatamansi. In addition, precipitation plays a crucial role in modeling the effects of climate change on the genus Nardostachys. This study provides theoretical guidance for the cultivation of N. chinensis.

APA, Harvard, Vancouver, ISO, and other styles

3

ITOKAWA, Hideji, Koichi MASUYAMA, Hiroshi MORITA, and Koichi TAKEYA. "Cytotoxic Sesquiterpenes from Nardostachys chinensis." CHEMICAL & PHARMACEUTICAL BULLETIN 41, no. 6 (1993): 1183–84. http://dx.doi.org/10.1248/cpb.41.1183.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chatterjee, Asima, Utpal Dutta, Debasish Bandyopadhyay, Anupam Nayak, Bidyut Basak, Avijit Banerji, and Julie Banerji. "An Overview of the Genus Nardostachys." Natural Product Communications 2, no. 11 (November 2007): 1934578X0700201. http://dx.doi.org/10.1177/1934578x0700201124.

Full text

Abstract:

Nardostachys jatamansi, a medicinally important herb of Nepalese origin, has been used for centuries in the Ayurvedic and Unani systems of medicine. In combination with Marsilea minuta it is being used as an antistress and anticonvulsant drug and also finds use in the treatment of epilepsy. Recently, it has been reported that N. jatamansi, which plays an important role in protecting from cerebral ischemia and liver damage, is also used for the treatment of osteoporosis and hypercalcemia. The other member of the genus Nardostachys, N. chinensis, possesses antifungal and antimalarial properties. It is also used in the treatment of skin dysfunction. A short summary of the chemical constituents of the two species along with their physical and biological properties is reported.

APA, Harvard, Vancouver, ISO, and other styles

5

Liu, Ming-Li, Ying-Hui Duan, Jin-Bo Zhang, Yang Yu, Yi Dai, and Xin-Sheng Yao. "Novel sesquiterpenes from Nardostachys chinensis Batal." Tetrahedron 69, no. 32 (August 2013): 6574–78. http://dx.doi.org/10.1016/j.tet.2013.05.134.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Wu, Pei-Qian, Yi-Fan Yu, Ye Zhao, Chun-Xue Yu, De-Juan Zhi, Feng-Ming Qi, Dong-Qing Fei, and Zhan-Xin Zhang. "Four novel sesquiterpenoids with their anti-Alzheimer's disease activity from Nardostachys chinensis." Organic & Biomolecular Chemistry 16, no. 46 (2018): 9038–45. http://dx.doi.org/10.1039/c8ob02319k.

Full text

Abstract:

Nardochinins A–D (1–4), four novel sesquiterpenoids, were isolated from Nardostachys chinensis. Nardochinin B (2) can significantly inhibit the Alzheimer's disease (AD) like symptom of worm paralysis.

APA, Harvard, Vancouver, ISO, and other styles

7

Satyal, Prabodh, Bhuwan K. Chhetri, Noura S. Dosoky, Ambika Poudel, and William N. Setzer. "Chemical Composition of Nardostachys grandiflora Rhizome Oil from Nepal – A Contribution to the Chemotaxonomy and Bioactivity of Nardostachys." Natural Product Communications 10, no. 6 (June 2015): 1934578X1501000. http://dx.doi.org/10.1177/1934578x1501000668.

Full text

Abstract:

The essential oil from the dried rhizome of Nardostachys grandiflora, collected from Jaljale, Nepal, was obtained in 1.4% yield, and a total of 72 compounds were identified constituting 93.8% of the essential oil. The rhizome essential oil of N. grandiflora was mostly composed of calarene (9.4%), valerena-4,7(11)-diene (7.1%), nardol A (6.0%), 1(10)-aristolen-9-ol (11.6%), jatamansone (7.9%), valeranal (5.6%), and cis-valerinic acid (5.7%). The chemical composition of N. grandiflora rhizome oil from Nepal is qualitatively very different than those from Indian, Chinese, and Pakistani Nardostachys essential oils. In this study we have evaluated the chemical composition and biological activities of N. grandiflora from Nepal. Additionally, 1(10)-aristolen-9-ol was isolated and the structure determined by NMR, and represents the first report of this compound from N. grandiflora. N. grandiflora rhizome oil showed in-vitro antimicrobial activity against Bacillus cereus, Escherichia coli, and Candida albicans (MIC = 156 μg/mL), as well as in-vitro cytotoxic activity on MCF-7 cells.

APA, Harvard, Vancouver, ISO, and other styles

8

Zhao, Ye, Bing Li, Yi-Fan Yu, Pei-Qian Wu, Chun-Xue Yu, Pan-Jie Su, De-Juan Zhi, Feng-Ming Qi, Dong-Qing Fei, and Zhan-Xin Zhang. "Narjatamanins A and B, a pair of novel epimers possessing a 2,3-seco-iridoid skeleton with an unusual 1,10-oxygen bridge from Nardostachys jatamansi and evaluation of their effects on worm paralysis in AD C. elegans." RSC Advances 9, no. 42 (2019): 24333–37. http://dx.doi.org/10.1039/c9ra04485j.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Yoon, Chi-Su, Dong-Cheol Kim, Jin-Soo Park, Kwan-Woo Kim, Youn-Chul Kim, and Hyuncheol Oh. "Isolation of Novel Sesquiterpeniods and Anti-neuroinflammatory Metabolites from Nardostachys jatamansi." Molecules 23, no. 9 (September 17, 2018): 2367. http://dx.doi.org/10.3390/molecules23092367.

Full text

Abstract:

Nardostachys jatamansi contains various types of sesquiterpenoids that may play an important role in the potency of plant’s anti-inflammatory effects, depending on their structure. In this study, five new sesquiterpenoids, namely kanshone L (1), kanshone M (2), 7-methoxydesoxo-narchinol (3), kanshone N (4), and nardosdaucanol (5), were isolated along with four known terpenoids (kanshone D (6), nardosinanone G (7), narchinol A (8), and nardoaristolone B (9)) from the rhizomes and roots of Nardostachys jatamansi. Their structures were determined by analyzing 1D and 2D NMR and MS data. Among the nine sesquiterpenoids, compounds 3, 4, and 8 were shown to possess dose-dependent inhibitory effects against lipopolysaccharide (LPS)-stimulated nitric oxide (NO) production in BV2 microglial cells. Furthermore, compounds 3, 4, and 8 exhibited anti-neuroinflammatory effects by inhibiting the production of pro-inflammatory mediators, including prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) proteins, as well as pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-12 and tumor necrosis factor-α (TNF-α), in LPS-stimulated BV2 microglial cells. Moreover, these compounds were shown to inhibit the activation of the NF-κB signaling pathway in LPS-stimulated BV2 microglial cells by suppressing the phosphorylation of IκB-α and blocking NF-κB translocation. In conclusion, five new and four known sesquiterpenoids were isolated from Nardostachys jatamansi, and compounds 3, 4, and 8 exhibited anti-neuroinflammatory effects in LPS-stimulated BV2 microglial cells through inhibiting of NF-κB signaling pathway.

APA, Harvard, Vancouver, ISO, and other styles

10

Purohit, Vijay K., R. S. Chauhan, Harish C. Andola, P. Prasad, M. C. Nautiyal, and A. R. Nautiyal. "Nardostachys jatamansiDC: Conservation, multiplication and policy issues." Medicinal Plants - International Journal of Phytomedicines and Related Industries 4, no. 3 (2012): 162. http://dx.doi.org/10.5958/j.0975-4261.4.3.019.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Sahu, Renu, H. J. Dhongade, Ajit Pandey, Poonam Sahu, Varsha Sahu, Dipali Patel, and Pranita Kashyap. "Medicinal Properties of Nardostachys jatamansi (A Review)." Oriental Journal of Chemistry 32, no. 2 (April 25, 2016): 859–66. http://dx.doi.org/10.13005/ojc/320211.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Shen, Xiu-yu, Yang Yu, Guo-dong Chen, Hua Zhou, Jin-fang Luo, Yi-han Zuo, Xin-sheng Yao, and Yi Dai. "Six new sesquiterpenoids from Nardostachys chinensis Batal." Fitoterapia 119 (June 2017): 75–82. http://dx.doi.org/10.1016/j.fitote.2017.04.004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Zhang, Jin-Bo, Ming-Li Liu, Chang Li, Yan Zhang, Yi Dai, and Xin-Sheng Yao. "Nardosinane-type sesquiterpenoids of Nardostachys chinensis Batal." Fitoterapia 100 (January 2015): 195–200. http://dx.doi.org/10.1016/j.fitote.2014.11.020.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Jha, Sweta, and Nirmla Devi Thakur. "Efficacy and Toxicity Study of Nardostachys Jatamansi DC and Valeriana Wallichii DC in Sleep Disorders." International Journal of Research in Engineering, Science and Management 3, no. 10 (October 20, 2020): 100–106. http://dx.doi.org/10.47607/ijresm.2020.343.

Full text

Abstract:

Background: Sleep disorders are common in general population and adversely affects the health related quality of life. Many people do not want to rely upon allopathic drug easily available over the counter because of their side effects. Cases of sleep disorders have exponentially increased during pandemic (Covid -19) and new term Covid-somnia have been coined for the same. Two Perennial herbs from Valerianeaceae family i.e Nardostachys jatamansi DC and Valeriana wallicii DC which are known as high value medicinal plants were selected for the study. Nardostachys jatamansi DC is used in the treatment of epilepsy, hysteria, convulsive ailments whereas rhizome of Valeriana wallicii DC have shown anxiolytic, stress releasing and antidepressant effects.Materials and Methods: The present study was undertaken to evaluate the efficacy and toxicity of the selected herbs for Sleep Disorders. A dose dependent Phenobarbitone - induced sleep time measurement study was performed. Further measure the effect of motor coordination, walking assay was performed.Results and Conclusions: Results of acute toxicity study and Irwin test indicated that selected extracts of Nardostachys jatamansi DC and Valeriana wallichii are safe. Further dose dependent Phenobarbitone - induced sleep time measurement study showed significant increase in selected three doses for this study (125, 250, 500 mg/kg body weight compared to control. The result of the study demonstrated that oral administration of extracts produced a dose-dependent decrease in sleep latency and increase in sleep duration in mice treated with extracts. These extracts exhibited a non- significant reduction in the number of foot slips in non-dose dependent manner relative to Phenobarbitone treated group.

APA, Harvard, Vancouver, ISO, and other styles

15

Sadri, Arash. "Letter to the Editor on “A System Pharmacology Study for Deciphering Anti Depression Activity of Nardostachys jatamansi”." Current Drug Metabolism 20, no. 5 (June 20, 2019): 411. http://dx.doi.org/10.2174/1389200220666190402125932.

Full text

Abstract:

This letter is with reference to a recent article published in Current Drug Metabolism; A System Pharmacology Study for Deciphering Anti Depression Activity of Nardostachys jatamansi. Unfortunately, there is a major error in the “material and method” section of the study, which jeopardizes the study’s goal.

APA, Harvard, Vancouver, ISO, and other styles

16

Zhang, Jin-Bo, Ming-Li Liu, Ying-Hui Duan, Hai-Yan Tian, Chang Li, Yi Dai, and Xin-Sheng Yao. "Novel nardosinane type sesquiterpenoids from Nardostachys chinensis Batal." Tetrahedron 70, no. 30 (July 2014): 4507–11. http://dx.doi.org/10.1016/j.tet.2014.05.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Wang, Zhimei, Xueqi Dong, Hong-Hong Zheng, Hu Zhang, Xu Deng, Ying-Peng Chen, Yan Zhu, Hong-Hua Wu, and Yan-Tong Xu. "Two isonardosinane-type sesquiterpenoids from Nardostachys jatamansi DC." Tetrahedron Letters 60, no. 30 (July 2019): 1992–95. http://dx.doi.org/10.1016/j.tetlet.2019.06.052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Bae, Gi-Sang, Hee-Je Park, Do-Yun Kim, Je-Moon Song, Tae-Hyeon Kim, Hyo-Jeong Oh, Ki-Jung Yun, et al. "Nardostachys jatamansi Protects Against Cerulein-Induced Acute Pancreatitis." Pancreas 39, no. 4 (May 2010): 520–29. http://dx.doi.org/10.1097/mpa.0b013e3181bd93ce.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Bagchi, Anjana, Yoshiteru Oshima, and Hiroshi Hikino. "Kanshones A and B, sesquiterpenoids of Nardostachys chinensis." Phytochemistry 27, no. 4 (1988): 1199–201. http://dx.doi.org/10.1016/0031-9422(88)80303-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Bagchi, Anjana, Yoshiteru Oshima, and Hiroshi Hikinot. "Kanshone C, a sesquiterpenoid of Nardostachys chinensis roots." Phytochemistry 27, no. 9 (January 1988): 2877–79. http://dx.doi.org/10.1016/0031-9422(88)80680-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Joshi, Hanumanthachar, and Milind Parle. "Nardostachys jatamansi Improves Learning and Memory in Mice." Journal of Medicinal Food 9, no. 1 (March 2006): 113–18. http://dx.doi.org/10.1089/jmf.2006.9.113.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Tanaka, Ken, and Katsuko Komatsu. "Comparative study on volatile components of Nardostachys Rhizome." Journal of Natural Medicines 62, no. 1 (October 6, 2007): 112–16. http://dx.doi.org/10.1007/s11418-007-0199-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Masuyama, Koichi, Hiroshi Morita, Koichi Takeya, and Hideji Itokawa. "Eudesm-11-en-2,4α-diol from Nardostachys Chinensis." Phytochemistry 34, no. 2 (September 1993): 567–68. http://dx.doi.org/10.1016/0031-9422(93)80047-v.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Paudyal, Mahesh P., Meena Rajbhandari, Purushottam Basnet, Shoji Yahara, and Mohan B. Gewali. "Quality assessment of the essential oils from Nardostachys jatamansi (d. Don) dc and Nardostachys chinensis batal obtained from Kathmandu valley market." Scientific World 10, no. 10 (September 20, 2012): 13–16. http://dx.doi.org/10.3126/sw.v10i10.6854.

Full text

Abstract:

The chemical composition and physicochemical parameters of the essential oils obtained from two species of Nardostachys available in Kathmandu market, N. jatamansi (D. Don) and N. chinensis Batal were determined. GC-MS technique was used for the analysis of the oils. Both oils were characterized by high content of sesquiterpenes. â-gurjunene and jatamansone were the major sesquiterpene components of both oils. Somewhat variation in the amount of chemical components was found in two different species. The physical and chemical parameters such as specific gravity, specific rotation, refractive index and saponification value, acid number, iodine number were very similar for both species. Both oils were, therefore, of comparable quality. Scientific World, Vol. 10, No. 10, July 2012 p13-16 DOI: http://dx.doi.org/10.3126/sw.v10i10.6854

APA, Harvard, Vancouver, ISO, and other styles

25

Jin, Qian, Ying Li, Pei Qun, Haiyan Xiang, Qiaozhi Yin, and Yuan Liu. "Determination of Inorganic Element Concentrations in Nardostachys jatamansi DC." Current Pharmaceutical Analysis 16, no. 7 (August 17, 2020): 892–900. http://dx.doi.org/10.2174/1573412915666190415145629.

Full text

Abstract:

Background:: Nardostachys jatamansi DC. is indigenous to the Himalayan regions of India and Tibetan plateau of China, and widely used as drugs for treating various neurological disorders, insomnia, hysteria and depressive illness. However, beyond the huge efforts to the organic components in N. jatamansi, the elemental contents have not been investigated, which are important for the quality control and biosafety evaluation of N. jatamansi. Objective:: In this study, we quantified the element concentrations in N. jatamansi. Methods:: Twenty-five N. jatamansi samples were collected in Sichuan, Tibet, Qinghai and Gansu provinces. The samples were digested and subjected to inductively coupled plasma optical emission spectrometer (ICP-OES) measurements. Results:: The results indicated that Al, B, Ba, Ca, Cd, Co, Cu, Fe, K, Mg, Mn, Mo, Na, Ni, P, Pd, Si, Sr, Ti and Zn were detected in N. jatamansi samples. The chemometrics approaches indicated that N. jatamansi samples from Sichuan and Tibet shared similar elemental patterns. The altitude did not statistically influence the elemental patterns of N. jatamansi samples, while the K, P, Ba and Cd showed meaningful decreases. The high Ba contents in all samples suggested the potential toxicity of heavy metal to patients. Conclusion:: The inorganic element quantification of N. jatamansi is useful in the genuine regional drug identification, quality control and biosafety evaluations.

APA, Harvard, Vancouver, ISO, and other styles

26

Salim, Sofiyan, Muzamil Ahmad, Khan Shoeb Zafar, Abdullah Shafique Ahmad, and Fakhrul Islam. "Protective effect of Nardostachys jatamansi in rat cerebral ischemia." Pharmacology Biochemistry and Behavior 74, no. 2 (January 2003): 481–86. http://dx.doi.org/10.1016/s0091-3057(02)01030-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Takaya, Yoshiaki, Ken-ichi Kurumada, Yoshie Takeuji, Hye-Sook Kim, Yasuharu Shibata, Naomi Ikemoto, Yusuke Wataya, and Yoshiteru Oshima. "Novel antimalarial guaiane-type sesquiterpenoids from Nardostachys chinensis roots." Tetrahedron Letters 39, no. 11 (March 1998): 1361–64. http://dx.doi.org/10.1016/s0040-4039(97)10844-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Tanitsu, Masa-aki, Yoshiaki Takaya, Megumi Akasaka, Masatake Niwa, and Yoshiteru Oshima. "Guaiane- and aristolane-type sesquiterpenoids of Nardostachys chinensis roots." Phytochemistry 59, no. 8 (April 2002): 845–49. http://dx.doi.org/10.1016/s0031-9422(01)00469-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Liu, Quan Feng, Youngjae Jeon, Yung-wei Sung, Jang Ho Lee, Haemin Jeong, Young-Mi Kim, Hye Sup Yun, et al. "Nardostachys jatamansi Ethanol Extract Ameliorates Aβ42 Cytotoxicity." Biological and Pharmaceutical Bulletin 41, no. 4 (2018): 470–77. http://dx.doi.org/10.1248/bpb.b17-00750.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Takaya, Yoshiaki, Megumi Akasaka, Yoshie Takeuji, Masa-aki Tanitsu, Masatake Niwa, and Yoshiteru Oshima. "Novel Guaianoids, Nardoguaianone E–I, from Nardostachys chinensis Roots." Tetrahedron 56, no. 39 (September 2000): 7679–83. http://dx.doi.org/10.1016/s0040-4020(00)00681-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Heo, Jee-In, Jeong-Hyeon Kim, Jeong-Min Lee, Sung Chan Kim, Jae-Bong Park, Jaebong Kim, and Jae-Yong Lee. "Mechanism for Antioxidant Activity of Nardostachys chinensis root Extract." Journal of Applied Biological Chemistry 57, no. 1 (March 31, 2014): 17–22. http://dx.doi.org/10.3839/jabc.2014.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Bagchi, Anjana, Yoshiteru Oshima, and Hiroshi Hikino. "Kanshones D and E, sesquiterpenoids of Nardostachys chinensis roots." Phytochemistry 27, no. 11 (January 1988): 3667–69. http://dx.doi.org/10.1016/0031-9422(88)80791-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Rao, Vidya S., Anjali Rao, and K. Sudhakar Karanth. "Anticonvulsant and neurotoxicity profile of Nardostachys jatamansi in rats." Journal of Ethnopharmacology 102, no. 3 (December 2005): 351–56. http://dx.doi.org/10.1016/j.jep.2005.06.031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Yoon, Chi-Su, Kwan-Woo Kim, Sang-Chan Lee, Youn-Chul Kim, and Hyuncheol Oh. "Anti-neuroinflammatory effects of sesquiterpenoids isolated from Nardostachys jatamansi." Bioorganic & Medicinal Chemistry Letters 28, no. 2 (January 2018): 140–44. http://dx.doi.org/10.1016/j.bmcl.2017.11.041.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

B, Deepa, Suchetha K, and Satheesh Rao. "ANTIDEPRESSANT ACTIVITY OF NARDOSTACHYS JATAMANSI IN ELECTRON BEAM IRRADIATED MICE." International Journal of Research in Ayurveda and Pharmacy 4, no. 1 (February 27, 2013): 101–3. http://dx.doi.org/10.7897/2277-4343.04135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Bae, Gi-Sang, Kyoung-Chel Park, Bon-Soon Koo, Sun-Bok Choi, Il-Joo Jo, Chang-Min Choi, Ho-Joon Song, and Sung-Joo Park. "The inhibitory effects of Nardostachys jatamansi on alcoholic chronic pancreatitis." BMB Reports 45, no. 7 (July 31, 2012): 402–7. http://dx.doi.org/10.5483/bmbrep.2012.45.7.076.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Min, Deul-Le, and Eun-Jung Park. "Effects of Nardostachys Jatamansi on Atopic Dermatitis-like Skin Lesions." Journal of Korean Oriental Pediatrics 26, no. 2 (May 31, 2012): 13–24. http://dx.doi.org/10.7778/jpkm.2012.26.2.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Zhang, Jin-Bo, Ming-Li Liu, Ying-Hui Duan, Hai-Yan Tian, Chang Li, Yi Dai, and Xin-Sheng Yao. "ChemInform Abstract: Novel Nardosinane Type Sesquiterpenoids from Nardostachys chinensis Batal." ChemInform 45, no. 50 (November 27, 2014): no. http://dx.doi.org/10.1002/chin.201450184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Bae, Gi-Sang, Sang-Wan Seo, Min-Sun Kim, Kyoung-Chel Park, Bon Soon Koo, Won-Seok Jung, Gil-Hwan Cho, et al. "The roots of Nardostachys jatamansi inhibits lipopolysaccharide-induced endotoxin shock." Journal of Natural Medicines 65, no. 1 (August 27, 2010): 63–72. http://dx.doi.org/10.1007/s11418-010-0458-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Panchal, Radhika, and Nutanbala N. Goswami. "Evaluation of antidepressant activity of hydro-alcoholic extract of rhizomes of Nardostachys jatamansi DC per se and in combination with fluoxetine in wistar albino rats and swiss albino mice." International Journal of Basic & Clinical Pharmacology 9, no. 1 (December 24, 2019): 32. http://dx.doi.org/10.18203/2319-2003.ijbcp20195761.

Full text

Abstract:

Background: Depression is a common mental disorder results due to deficiency of neurotransmitter in the brain. Various medicinal properties of jatamansi are mentioned in Ayurveda. This study evaluated effect of hydro-alcoholic extract of rhizomes of Nordostachys jatamansi DC per se and in combination with fluoxetine in wistar albino rats and swiss albino mice.Methods: Animals of either sex were selected and randomly divided in test group. Jatamansi extract 10:1 and fluoxetine hydrochloride dissolved in distilled water were used. Animals were tested for forced swimming test, tail suspension test and locomotor after given test drug. Results were compared with control and analysed.Results: Nardostachys jatamansi DC, when given to rats showed dose dependent increase in number of rotation during forced swimming test in rats. During forced swimming test in glass jar statistically significant decrease in immobility was observed. Nardostachys jatamansi DC, when given to mice dose dependent statistically significant decrease in immobility time, swimming time and climbing observed. When given along with combination of fluoxetine it shows statistically significant difference in result, confirmed that it can have synergistic antidepressant activity. When used for locomotor activity in mice none of the test drugs significantly increase or decrease the locomotor activity.Conclusions: Jatamansi showed antidepressant like property in various tests conducted on rats and mice. It showed statistically significant result with increasing dose and had synergic effect when given along with fluoxetine.

APA, Harvard, Vancouver, ISO, and other styles

41

M., Damodara Gowda K., Lathika Shetty, Krishna A. P., Suchetha Kumari N., Ganesh Sanjeev, Naveen P., and Sharada V. "ETHANOLIC EXTRACT OF NARDOSTACHYS JATAMANSI POTENTIATES HAEMATOPOIETIC SYSTEM IN ALBINO WISTAR RATS." Journal of Health and Allied Sciences NU 03, no. 01 (March 2013): 25–29. http://dx.doi.org/10.1055/s-0040-17036329.

Full text

Abstract:

Abstract Background and Objective: The consumption of a variety of local herbs and vegetables by man contributes significantly to the improvement of human health in terms of prevention, and/or cure of diseases because plants have long served as a useful and natural source of therapeutic agents. The present study aims at investigating the hematopoietic effect of Nardostachys jatamansi extract (NJE) in albino wistar rats. Materials and Methods: Twenty four male albino wistar rats were used and divided into 4 groups of 6 animals each. The Group I served as a normal control. The animals of Group II, III and IV were administered orally with aqueous suspension of NJE at the dosage of 100 mg/kg, 200 mg/kg and 400 mg/kg body weight for 15 consecutive days respectively. Then blood was Blood was collected and used for the estimation of Peripheral blood counts (RBC, WBC), haemoglobin, thrombocyte count and Hematocrit was determined at day 0.25 (6 hrs), 0.5 (12 hrs), 1, 2, 5, 10, and 15 days of treatment using automated haematology analyzer. Body weight was also recorded regularly. Statistical Analysis was done by one way ANOVA followed by Bonferroni post hoc test for multiple comparisons using SPSS-16. P value less than 0.05 was considered the level of significance. Results: All the parameters have shown a significant increase (p = 0.000) in experimental animals except body weight which was increased insignificantly. Conclusion: Nardostachys jatamansi extract can be attributed to stimulating or protecting hematopoiesis.

APA, Harvard, Vancouver, ISO, and other styles

42

Kim, Kwan-Woo, Chi-Su Yoon, Sung-Joo Park, Gi-Sang Bae, Dong-Gu Kim, Youn-Chul Kim, and Hyuncheol Oh. "Chemical Analysis of the Ingredients of 20% Aqueous Ethanol Extract of Nardostachys jatamansi through Phytochemical Study and Evaluation of Anti-Neuroinflammatory Component." Evidence-Based Complementary and Alternative Medicine 2021 (April 22, 2021): 1–14. http://dx.doi.org/10.1155/2021/5901653.

Full text

Abstract:

Nardostachys spp. have been widely used in Asia as a folk medicine. In particular, the extracts of Nardostachys jatamansi, a species that grows in China, India, and Tibet, have been used to treat mental disorders, hyperlipidemia, hypertension, and convulsions. In this investigation, the potential of 20% aqueous ethanol extract of N. jatamansi (NJ20) as a botanical drug was explored by chemically investigating its constituents and its anti-neuroinflammatory effects on lipopolysaccharide- (LPS-) induced in vitro and in vivo models. Nine secondary metabolites were isolated and identified from NJ20, and quantitative analysis of these metabolites revealed desoxo-narchinol A as the major constituent. In LPS-challenged cells, pretreatment with NJ20 inhibited the LPS-induced excessive production of proinflammatory mediators, such as nitric oxide, prostaglandin E2, interleukin- (IL-) 1β, IL-6, and tumor necrosis factor-α. NJ20 also attenuated the overexpression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2. Additionally, pre-intraperitoneal injection of NJ20 downregulated the mRNA overexpression of IL-1β, IL-6, and iNOS in the prefrontal cortex, hypothalamus, and hippocampus of the LPS-stimulated C57BL/c mouse model. Chemical and biological investigations of NJ20 revealed that it is a potential inhibitor of LPS-induced neuroinflammatory responses in microglial cells and mouse models. The major active constituent of NJ20, desoxo-narchinol A, demonstrated anti-neuroinflammatory effects. Hence, our findings indicate that NJ20 may be a promising herbal mixture for developing a functional product and/or herbal drug for treating neuroinflammatory diseases.

APA, Harvard, Vancouver, ISO, and other styles

43

Ali, Shakir, Khursheed A. Ansari, M. A. Jafry, H. Kabeer, and G. Diwakar. "Nardostachys jatamansi protects against liver damage induced by thioacetamide in rats." Journal of Ethnopharmacology 71, no. 3 (August 2000): 359–63. http://dx.doi.org/10.1016/s0378-8741(99)00153-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

BAE, GI-SANG, KYOUNG-CHEL PARK, BON SOON KOO, IL-JOO JO, SUN BOK CHOI, HO-JOON SONG, and SUNG-JOO PARK. "Nardostachys jatamansi inhibits severe acute pancreatitis via mitogen-activated protein kinases." Experimental and Therapeutic Medicine 4, no. 3 (June 18, 2012): 533–37. http://dx.doi.org/10.3892/etm.2012.612.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Takaya, Yoshiaki, Megumi Akasaka, Yoshie Takeuji, Masa-aki Tanitsu, Masatake Niwa, and Yoshiteru Oshima. "ChemInform Abstract: Novel Guaianoids, Nardoguaianone E-I, from Nardostachys chinensis Roots." ChemInform 32, no. 2 (January 9, 2001): no. http://dx.doi.org/10.1002/chin.200102186.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Rehman, Tayyeba, and Saeed Ahmad. "Nardostachys chinensis Batalin: A review of traditional uses, phytochemistry, and pharmacology." Phytotherapy Research 33, no. 10 (July 29, 2019): 2622–48. http://dx.doi.org/10.1002/ptr.6447.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Tanitsu, Masa-aki, Toshiaki Takaya, Megumi Akasaka, Masatake Niwa, and Yoshiteru Oshima. "ChemInform Abstract: Guaiane- and Aristolane-Type Sesquiterpenoids of Nardostachys chinensis Roots." ChemInform 33, no. 34 (May 20, 2010): no. http://dx.doi.org/10.1002/chin.200234208.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

TAKAYA, Y., K. KURUMADA, Y. TAKEUJI, H. S. KIM, Y. SHIBATA, N. IKEMOTO, Y. WATAYA, and Y. OSHIMA. "ChemInform Abstract: Novel Antimalarial Guaiane-Type Sequiterpenoids from Nardostachys chinensis Roots." ChemInform 29, no. 22 (June 22, 2010): no. http://dx.doi.org/10.1002/chin.199822132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Wang, Li-Xia, Xian-Jun Jiang, Xiang-Mei Li, Mei-Fen Mao, Guo-Zhu Wei, and Fei Wang. "Aristolane-type Sesquiterpenoids from Nardostachys chinensis and Revised Structure of Aristolanhydride." Natural Products and Bioprospecting 9, no. 2 (March 8, 2019): 149–55. http://dx.doi.org/10.1007/s13659-019-0200-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Patil, Rupali, SanjayB Kasture, and YogeshA Hiray. "Reversal of reserpine-induced orofacial dyskinesia and catalepsy by Nardostachys jatamansi." Indian Journal of Pharmacology 44, no. 3 (2012): 340. http://dx.doi.org/10.4103/0253-7613.96307.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!